Magazine Article | November 8, 2017

Industry Explorers Blaze On: Deborah Dunsire

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

The stories of longtime leaders, still active in the industry, sharing their historical perspectives on life sciences industry innovation.

To transform: to start with a scientific hypothesis, use it to create or isolate a potentially therapeutic substance, devise and conduct bench tests, move the compound into preclinical, then clinical trials, and with a great measure of luck, finally gain approval to take the drug to market and make it available to patients. Some people disdain the drug-commercialization process as fraught with fraud and conflict of interest. Others celebrate it as … pure magic. In the latter camp would be Deborah Dunsire, who has lived and worked in a world driven by commercial drug development for three decades.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.